• Print
  • Send to a friend
  • Comment (0)
  •  

Who's doing deals in Ottawa?

(Stock image)

(Stock image)

Published on May 28, 2012
Published on May 28, 2012
OBJ Staff  RSS Feed

PiiComm Inc., TrueNorth Avionics, Versature, Pharmagap Inc. and Clinical Value Corp. among local firms recently announcing new agreements.

Topics :
PharmaGap Inc. , PiiComm , Stratix , Ottawa , Canada , United States

Ottawa's PiiComm Inc. has teamed with Norcross, Ga.-based Stratix Corp. to offer their enterprise mobile software and managed service solutions to customers who have operations in Canada and the United States. Clients are in field service, transportation and logistics, and retail. Other contract details were not released.

TrueNorth Avionics announced a pair of contracts. Switzerland-based AMAC Aerospace selected the Ottawa company to provide its airborne telecommunications system for an Airbus ACJ A319 VIP Aircraft, which includes capabilities such as high-definition voice, cordless and corded handsets and Wi-Fi. Texas’s L-3 Communications selected the same technology for use aboard a Boeing 747-8 head-of-state aircraft. No financial details were disclosed.

Versature has expanded its reach by 270 per cent to include Canadian markets outside of its traditional customer base of major cities such as Ottawa, Toronto and Halifax. The hosted PBX phone system provider now services 950 cities and towns across the country, up from 350. Versature services include call control, fax-to-email and conferencing.

PharmaGap Inc.'s (TSX-V:GAP) board of directors authorized conditional approval to exclusively license the company’s lead cancer drug with fellow Ottawa firm Clinical Value Corp. The agreement still must pass several milestones, including final documentation, a fairness opinion and majority support from disinterested shareholders of PharmaGap. CVC will pay $40,000 monthly to PharmaGap and provide management services for three years for development and testing, and share revenues from the licensing or sale of the lead drug and related intellectual property. CVC will also assume PharmaGap trade payables and liabilities (up to $500,000) and obligations for amounts owing to SC Stormont ($1.7 million and further costs as they are accrued.) Officials plan to close the deal July 31.

Submit a comment

Submit a comment (we keep all emails private)
Agreement

We ask that users remain courteous. You may not post insulting, discriminatory or inappropriate content, which may be removed at our discretion. We are not responsible for user content and opinions. Use of this site as well as content submission & ownership are governed by our Conditions of Use and Privacy Policy.

Member organizations should be non-profit in nature, and promote legal activities. Any organization found promoting illegal activities or commercial products or services will be deleted from the site.

I agree with these conditions.

Advertising

Expert bloggers

Equitas Consultants Inc.
Blogger
Ron Prehogan
Family Business Longevity: The...
Design 1st
Blogger
Kevin J. Bailey
The Backyard Inventor's Maze:
Impact Public Affairs
Blogger
Huw Williams
How to be a PR Star!

More bloggers here

CASE STUDY VIDEOS

Building stronger communities across Ottawa
Domicile Developments

An investment in yourself
LC Fitness Studio

No surprises, no upselling
RE/MAX Citywide Realty

Newsletter

Please enter your email to receive our free newsletter

Subscribe to news alerts

Advertising